152 related articles for article (PubMed ID: 31303174)
1. The need for evidence-based strategies and tools for onchocerciasis elimination in Africa.
Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
Infect Dis Poverty; 2019 Jul; 8(1):62. PubMed ID: 31303174
[TBL] [Abstract][Full Text] [Related]
2. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
Richards FO; Nwoke BEB; Zarroug I; Tukahebwa E; Negussu N; Higazi TB; Oguttu D; Tadesse Z; Miri E; Aziz N; Habomugisha P; Katabarwa M
Infect Dis Poverty; 2019 Jul; 8(1):52. PubMed ID: 31303175
[TBL] [Abstract][Full Text] [Related]
3. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
[TBL] [Abstract][Full Text] [Related]
4. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
[TBL] [Abstract][Full Text] [Related]
5. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala.
Wkly Epidemiol Rec; 2016 Oct; 91(43):501-5. PubMed ID: 27801556
[No Abstract] [Full Text] [Related]
6. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
[TBL] [Abstract][Full Text] [Related]
7. River blindness.
Unnasch TR
Lancet; 2002 Jul; 360(9328):182-3. PubMed ID: 12133647
[No Abstract] [Full Text] [Related]
8. Ten years of NGDO action against river blindness.
Drameh PS; Richards FO; Cross C; Etya'alé DE; Kassalow JS
Trends Parasitol; 2002 Sep; 18(9):378-80. PubMed ID: 12377246
[TBL] [Abstract][Full Text] [Related]
9. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
[TBL] [Abstract][Full Text] [Related]
11. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
12. Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness.
Walker M; Pion SDS; Fang H; Gardon J; Kamgno J; Basáñez MG; Boussinesq M
Clin Infect Dis; 2017 Nov; 65(12):2026-2034. PubMed ID: 29020189
[TBL] [Abstract][Full Text] [Related]
13. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
[TBL] [Abstract][Full Text] [Related]
14. River Blindness: Mathematical Models for Control and Elimination.
Basáñez MG; Walker M; Turner HC; Coffeng LE; de Vlas SJ; Stolk WA
Adv Parasitol; 2016; 94():247-341. PubMed ID: 27756456
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
Duerr HP; Eichner M
Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
[TBL] [Abstract][Full Text] [Related]
16. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
[TBL] [Abstract][Full Text] [Related]
17. Population biology of human onchocerciasis.
Basáñez MG; Boussinesq M
Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):809-26. PubMed ID: 10365406
[TBL] [Abstract][Full Text] [Related]
18. Diagnostics for onchocerciasis in the era of elimination.
Unnasch TR; Golden A; Cama V; Cantey PT
Int Health; 2018 Mar; 10(suppl_1):i20-i26. PubMed ID: 29471336
[TBL] [Abstract][Full Text] [Related]
19. Good news on a tropical disease.
Kennedy D
Science; 2002 May; 296(5572):1365. PubMed ID: 12029099
[No Abstract] [Full Text] [Related]
20. The Onchocerciasis Elimination Program for the Americas (OEPA).
Sauerbrey M
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]